# Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

> **NCT01374841** · PHASE2 · UNKNOWN · sponsor: **European Institute of Oncology** · enrollment: 20 (estimated)

## Conditions studied

- Hematologic Neoplasms

## Interventions

- **DRUG:** Cyclophosphamide
- **OTHER:** Hematopoietic Stem Cell Transplantation,

## Key facts

- **NCT ID:** NCT01374841
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01374841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01374841, "Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01374841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*